Zika virus infections Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.
Zika virus infections Pipeline Analysis report covers drugs of 4 companies currently in different phases of development. Zika virus infections are spread via an infected mosquito bite, Aedes aegypti and Aedes albopictus. Zika can be passed on to a foetus from a pregnant woman infected with the virus and can cause birth defects, miscarriage and stillbirth. Symptoms of the infections include fever, rash, headache, red eyes among others. There is no vaccine or medicine for zika virus infections.
The report provides Zika virus infections treatment drugs by company, phases of development including products in early discovery stage and NDA filing, molecule type, route of administration and region. The report will help to evaluate the collaboration, in-licensing and out-licensing opportunities, formulating business development strategies and tracking the activities of the key market players. Epidemiology, major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Various databases (for patents and Clinical Trials), studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.
Major industry players profiled as part of the report are Takeda Pharmaceutical Company Limited, Humabs BioMed SA, Valneva SE, Moderna Therapeutics and Emergent BioSolutions Inc. among others.
Scope:
By Company
By Phase
By Molecule Type
By Region
By Route of Administration